Impact of effective prevention and management of febrile neutropenia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

1. All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia.Journal of clinical medicine · 2023
   Article
2. Loss of microbiota-derived protective metabolites after neutropenic fever.Scientific reports · 2022
   Article
3. Febrile Neutropenia Duration Is Associated with the Severity of Gut Microbiota Dysbiosis in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.Cancers · 2022
   Article
4. Real-world use of granulocyte colony-stimulating factor in ambulatory breast cancer patients: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
   Observational
5. The Emergency Care of Patients With Cancer: Setting the Research Agenda.Annals of emergency medicine · 2016
   Article
6. Compatibility of Biosimilar Filgrastim with Cytotoxic Chemotherapy during the Treatment of Malignant Diseases (VENICE): A Prospective, Multicenter, Non-Interventional, Longitudinal Study.Advances in therapy · 2016
   Article
7. Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
   Observational
8. Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2014
   Article
9. Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman.International journal of clinical pharmacy · 2013
   Observational
10. Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model.British journal of cancer · 2012
    Article
11. Prevention of febrile neutropenia: use of prophylactic antibiotics.British journal of cancer · 2009
    Article
12. Management of chemotherapy-associated febrile neutropenia.British journal of cancer · 2009
    Article
13. Effect of an education program on knowledge, self-care behavior and handwashing competence on prevention of febrile neutropenia among breast cancer patients receiving Doxorubicin and Cyclophosphamide in Chemotherapy Day Centre.Asia-Pacific journal of oncology nursing
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as